Alcobra Ltd. to Release Third Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on November 17
05 nov. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
FDA Grants Fast Track Designation to Alcobra's MDX for Fragile X Syndrome
21 sept. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Second Quarter 2015 Financial Results and Provides Corporate Update
13 août 2015 07h00 HE
|
Alcobra Ltd.
Conference Call & Webcast today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release Second Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on August 13
03 août 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Election of Dr. Joao Siffert to Board of Directors
13 juil. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Isreal, July 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Results From Phase 2 Clinical Trial of MDX for Fragile X Syndrome
24 juin 2015 06h00 HE
|
Alcobra Ltd.
Study Did Not Meet Primary Endpoint of Change on the ADHD RS-IV Inattentive Subscale
Statistically Significant Improvements Seen on Two Secondary Endpoints: the Vineland Adaptive Behavior Scale...
Alcobra Ltd. to Present Results of Phase II Fragile X Trial in a Conference Call & Webcast Presentation on Wednesday, June 24
23 juin 2015 16h01 HE
|
Alcobra Ltd.
TEL AVIV, Israel, June 23, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Two Conferences in June
28 mai 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, May 28, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces First Quarter 2015 Financial Results and Provides Corporate Update
06 mai 2015 07h30 HE
|
Alcobra Ltd.
Alcobra Provides Update on Results of FDA Meeting
Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, May 6, 2015 (GLOBE NEWSWIRE) -- Alcobra...
Alcobra Ltd. to Participate at Two Conferences in May
27 avr. 2015 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, April 27, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...